Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:57 pm Purchase |
2024-09-30 | 13G | HUYA Inc. HUYA |
Point72 Asset Management, L.P. | 163,579 0.200% |
163,579 (New Position) |
Filing History |
| 2024-11-14 7:57 pm Sale |
2024-09-30 | 13G | Fox Corporation FOXA |
Point72 Asset Management, L.P. | 70,800 0.100% |
-11,975,318 (-99.41%) |
Filing History |
| 2024-11-14 7:56 pm Sale |
2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO |
Point72 Asset Management, L.P. | 888,870 2.000% |
-760,870 (-46.12%) |
Filing History |
| 2024-11-14 7:55 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management, L.P. | 2,468,128 8.000% |
855,489 (+53.05%) |
Filing History |
| 2024-11-14 7:55 pm Purchase |
2024-09-30 | 13G | Liberty Live Group LLYVA |
Point72 Asset Management, L.P. | 1,576,057 6.200% |
288,908 (+22.45%) |
Filing History |
| 2024-11-14 7:55 pm Sale |
2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 2,300,643 2.900% |
-1,116,257 (-32.67%) |
Filing History |
| 2024-11-14 7:55 pm Sale |
2024-09-30 | 13G | MediWound Ltd. MDWD |
Point72 Asset Management, L.P. | 11,727 0.100% |
-809,773 (-98.57%) |
Filing History |
| 2024-11-14 7:54 pm Sale |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Point72 Asset Management, L.P. | 2,997,453 3.700% |
-2,935,455 (-49.48%) |
Filing History |
| 2024-11-14 7:54 pm Purchase |
2024-09-30 | 13G | Korro Bio, Inc. KRRO |
Point72 Asset Management, L.P. | 721,681 7.800% |
179,024 (+32.99%) |
Filing History |
| 2024-11-14 7:54 pm Sale |
2024-09-30 | 13G | Iterum Therapeutics plc ITRM |
Point72 Asset Management, L.P. | 0 0.000% |
-850,001 (Position Closed) |
Filing History |
| 2024-11-14 7:54 pm Sale |
2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX |
Point72 Asset Management, L.P. | 46,685 0.100% |
-2,970,408 (-98.45%) |
Filing History |
| 2024-11-14 7:53 pm Sale |
2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU |
Point72 Asset Management, L.P. | 2,709,292 3.000% |
-1,723,310 (-38.88%) |
Filing History |
| 2024-11-14 7:53 pm Purchase |
2024-09-30 | 13G | Lumentum Holdings Inc. LITE |
Point72 Asset Management, L.P. | 4,271,830 6.300% |
889,432 (+26.30%) |
Filing History |
| 2024-11-14 7:53 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Point72 Asset Management, L.P. | 1,760,207 9.600% |
1,002,022 (+132.16%) |
Filing History |
| 2024-11-14 7:53 pm Sale |
2024-09-30 | 13G | C4 Therapeutics, Inc. CCCC |
Point72 Asset Management, L.P. | 1,313,747 1.900% |
-1,362,949 (-50.92%) |
Filing History |
| 2024-11-14 7:53 pm Purchase |
2024-09-30 | 13G | Avid Bioservices, Inc. CDMO |
Point72 Asset Management, L.P. | 5,282,640 8.300% |
2,056,634 (+63.75%) |
Filing History |
| 2024-11-14 7:52 pm Sale |
2024-09-30 | 13G | Morphic Holding, Inc. MORF |
Point72 Asset Management, L.P. | 0 0.000% |
-4,591,000 (Position Closed) |
Filing History |
| 2024-11-14 7:51 pm Sale |
2024-09-30 | 13G | Health Catalyst, Inc. HCAT |
Point72 Asset Management, L.P. | 619,020 1.000% |
-3,540,434 (-85.12%) |
Filing History |
| 2024-11-14 7:51 pm Purchase |
2024-09-30 | 13G | Cybin Inc. CYBN |
Point72 Asset Management, L.P. | 292,397 1.400% |
292,397 (New Position) |
Filing History |
| 2024-11-14 7:50 pm Sale |
2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
Point72 Asset Management, L.P. | 247,055 0.200% |
-4,620,651 (-94.92%) |
Filing History |